Cargando…
Molecular immune pathogenesis and diagnosis of COVID-19
Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Xi'an Jiaotong University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104082/ https://www.ncbi.nlm.nih.gov/pubmed/32282863 http://dx.doi.org/10.1016/j.jpha.2020.03.001 |
_version_ | 1783512171413504000 |
---|---|
author | Li, Xiaowei Geng, Manman Peng, Yizhao Meng, Liesu Lu, Shemin |
author_facet | Li, Xiaowei Geng, Manman Peng, Yizhao Meng, Liesu Lu, Shemin |
author_sort | Li, Xiaowei |
collection | PubMed |
description | Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) in the twenty-first century. In this minireview, we provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection. |
format | Online Article Text |
id | pubmed-7104082 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Xi'an Jiaotong University |
record_format | MEDLINE/PubMed |
spelling | pubmed-71040822020-03-31 Molecular immune pathogenesis and diagnosis of COVID-19 Li, Xiaowei Geng, Manman Peng, Yizhao Meng, Liesu Lu, Shemin J Pharm Anal Review Paper Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) in the twenty-first century. In this minireview, we provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection. Xi'an Jiaotong University 2020-04 2020-03-05 /pmc/articles/PMC7104082/ /pubmed/32282863 http://dx.doi.org/10.1016/j.jpha.2020.03.001 Text en © 2020 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Paper Li, Xiaowei Geng, Manman Peng, Yizhao Meng, Liesu Lu, Shemin Molecular immune pathogenesis and diagnosis of COVID-19 |
title | Molecular immune pathogenesis and diagnosis of COVID-19 |
title_full | Molecular immune pathogenesis and diagnosis of COVID-19 |
title_fullStr | Molecular immune pathogenesis and diagnosis of COVID-19 |
title_full_unstemmed | Molecular immune pathogenesis and diagnosis of COVID-19 |
title_short | Molecular immune pathogenesis and diagnosis of COVID-19 |
title_sort | molecular immune pathogenesis and diagnosis of covid-19 |
topic | Review Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104082/ https://www.ncbi.nlm.nih.gov/pubmed/32282863 http://dx.doi.org/10.1016/j.jpha.2020.03.001 |
work_keys_str_mv | AT lixiaowei molecularimmunepathogenesisanddiagnosisofcovid19 AT gengmanman molecularimmunepathogenesisanddiagnosisofcovid19 AT pengyizhao molecularimmunepathogenesisanddiagnosisofcovid19 AT mengliesu molecularimmunepathogenesisanddiagnosisofcovid19 AT lushemin molecularimmunepathogenesisanddiagnosisofcovid19 |